Blood News and Research

RSS

COVID-19 booster shot in autumn will effectively protect against existing and future variants

Scientists at the University of Nottingham have confirmed that an autumn 'booster' dose of a Covid-19 vaccine will be an effective way to protect people from existing, and potentially future, variants of concern.

11 Aug 2021

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Scientists from Germany and Belgium have recently described the immunogenicity of a plant-based virus-like particle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine induces robust antibody and T cell responses for at least 6 months. Moreover, the vaccine demonstrates potent neutralizing efficacy against the B.1.1.7, B.1.351, and P1 variants of SARS-CoV-2.

11 Aug 2021

Green spaces, especially forest, reduce COVID-19 incidence, study says

An intriguing new study reveals that the closer you are to green spaces, especially forests, the less likely you are to be infected with SARS-CoV-2.

10 Aug 2021

Study uncovers epigenetic mechanism that mediates a link between fetal conditions and later health

A study at Tampere University has identified one possible epigenetic mechanism through which the conditions at conception may affect the health of an individual in later life.

10 Aug 2021

NYU Langone and Perlmutter Cancer Center expand lung cancer screening services to more locations

As part of its mission to bring high-quality healthcare services closer to patients, NYU Langone Health and Perlmutter Cancer Center have expanded the Lung Cancer Screening Program to more than a dozen additional locations throughout its network in Manhattan, Brooklyn, Queens, and on Long Island.

10 Aug 2021

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Beige is considered a calming paint color, and scientists have new evidence that beige fat has a similar impact on the brain, bringing down the inflammation associated with the more common white fat and providing protection from dementia.

10 Aug 2021

Study identifies Foxo1 gene as a potential treatment target for hereditary lymphedema

A University of South Florida preclinical study unexpectedly identified the gene Foxo1 as a potential treatment target for hereditary lymphedema.

10 Aug 2021

Study shows how hormones released after brain injury contribute to movement problems

Hormones released after a brain injury contributes to movement problems on the left and right sides of the body, scientists from Uppsala University and elsewhere can now show in a new study in rats.

10 Aug 2021

New estimate of total immunity to SARS-CoV-2 in Texas

According to researchers in Texas, a lack of appropriate testing in the US has led to an underestimation of seroprevalence in the U.S., thus making it difficult to estimate population immunity to SARS-CoV-2 or vaccination.

10 Aug 2021

Acclaimed Pacific Shores Medical Group joins City of Hope

City of Hope, a world-renowned cancer research and treatment center, today announced that acclaimed Pacific Shores Medical Group has joined City of Hope.

9 Aug 2021

Children's Hospital Colorado announces participation in pivotal trial of synthetic restorative pulmonary valve

Children's Hospital Colorado today announced it has joined the Xplore2/Pivotal trial, and is actively enrolling patients for the first-ever pivotal trial of a synthetic restorative pulmonary valve.

9 Aug 2021

Polymer-based coating for blood vessels can reduce organ rejection following a transplant

Researchers have found a way to reduce organ rejection following a transplant by using a special polymer to coat blood vessels on the organ to be transplanted.

9 Aug 2021

New biocompatible glue could quickly seal injured tissues and stop bleeding

Inspired by the sticky substance that barnacles use to cling to rocks, MIT engineers have designed a strong, biocompatible glue that can seal injured tissues and stop bleeding.

9 Aug 2021

Young, healthy adult infected by COVID-19 suffers CNS lymphocytic vasculitis

Although COVID-19 is primarily treated as a respiratory disease, patients often experience neurological problems, such as headaches, anxiety, depression and cognitive issues, which can persist long after other symptoms have resolved.

9 Aug 2021

Tiny gel drops for the development of regenerative therapies

Tiny drops that resemble an extracellular matrix can be used to culture cells for delivery into the human body.

9 Aug 2021

Research finds disruption of flight-or-fight response in healthy young people diagnosed with COVID-19

New research published in The Journal of Physiology found that otherwise healthy young people diagnosed with COVID-19, regardless of their symptom severity, have problems with their nervous system when compared with healthy control subjects.

9 Aug 2021

Metformin can help counter mitochondrial dysfunction in patients with type-2 diabetes

Research staff have shown that metformin, an efficient drug against type-2 diabetes, can improve the mitochondrial function in patients with this disease.

9 Aug 2021

New regional policy to guide EMS response could improve stroke care

Patients with a suspected acute ischemic stroke who are taken by emergency medical services (EMS) directly to comprehensive stroke centers rather than the nearest stroke center for care are more likely to receive endovascular therapy, according to research led by investigators at the University of Chicago Medicine, in collaboration with local healthcare and emergency response groups.

9 Aug 2021

New technique can be used to directly image atherosclerotic plaques

If heart attacks blared a warning signal, patients would have a better chance of avoiding them. That's the idea behind a new imaging technique developed by a Spartan-led team of researchers.

9 Aug 2021

Dileucine more effective than leucine in stimulating muscle-building in humans

In a randomized control study of 10 healthy young men, researchers compared how consuming the single amino acid leucine or its two-molecule equivalent, dileucine, influenced muscle-building and breakdown.

9 Aug 2021

Blood News and Research

COVID-19 booster shot in autumn will effectively protect against existing and future variants

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Green spaces, especially forest, reduce COVID-19 incidence, study says

Study uncovers epigenetic mechanism that mediates a link between fetal conditions and later health

NYU Langone and Perlmutter Cancer Center expand lung cancer screening services to more locations

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Study identifies Foxo1 gene as a potential treatment target for hereditary lymphedema

Study shows how hormones released after brain injury contribute to movement problems

New estimate of total immunity to SARS-CoV-2 in Texas

Acclaimed Pacific Shores Medical Group joins City of Hope

Children's Hospital Colorado announces participation in pivotal trial of synthetic restorative pulmonary valve

Polymer-based coating for blood vessels can reduce organ rejection following a transplant

New biocompatible glue could quickly seal injured tissues and stop bleeding

Young, healthy adult infected by COVID-19 suffers CNS lymphocytic vasculitis

Tiny gel drops for the development of regenerative therapies

Research finds disruption of flight-or-fight response in healthy young people diagnosed with COVID-19

Metformin can help counter mitochondrial dysfunction in patients with type-2 diabetes

New regional policy to guide EMS response could improve stroke care

New technique can be used to directly image atherosclerotic plaques

Dileucine more effective than leucine in stimulating muscle-building in humans

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News